5-Year Overall Survival In Columbus: A Randomized Phase 3 Study Of Encorafenib Plus Binimetinib Versus Vemurafenib Or Encorafenib In Patients With Braf(V600)-Mutated Melanoma

R. Dummer,K. Flaherty, C. Robert,A. Arance,J. W. De Groot,C. Garbe,H. Gogas, R. Gutzmer, I. Krajsova,G. Liszkay,C. Loquai, M. Mandala,D. Schadendorf,N. Yamazaki, M. D. Pickard, F. Zohren,M. Edwards,P. A. Ascierto

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT(2021)

引用 0|浏览9
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要